CureVac sues Moderna for patent infringement over COVID-19 vaccines [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
Moderna's COVID-19 vaccine Spikevax ?infringed CureVac patents related to messenger RNA (mRNA) technology. CureVac said in the ?lawsuit that Moderna copied its technology for stabilizing fragile mRNA to use in vaccines and requested royalties from Moderna's Spikevax sales in damages. Germany-based BioNTech -- which partnered with Pfizer ?to create the ?competing COVID-19 vaccine Comirnaty -- acquired CureVac last year. BioNTech filed a separate U.S. patent ?lawsuit against Moderna over its next-generation mNEXSPIKE COVID-19 shot in February. Moderna said in a statement that it was aware ?of the ?lawsuit filed on Friday ?and will defend itself. ?Spokespeople for CureVac and BioNTech did not immediately respond to requests for comment on the lawsuit. The case is part of a wave of high-stakes patent lawsuits from biotech companies seeking royalties for the technology used in ?blockbuster COVID-19 vaccines. Moderna sued ?Pfizer and BioNTech for patent ?infringement over Comirnaty
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Alnylam Pharmaceuticals (ALNY) Advances Diabetes Drug Into Phase 2 Trial [Yahoo! Finance]Yahoo! Finance
- CureVac sues Moderna for patent infringement over COVID-19 vaccines [Yahoo! Finance Canada]Yahoo! Finance Canada
- Alnylam Pharmaceuticals: Cutting-Edge Pharma Stock Still Feels A Little Overvalued [Seeking Alpha]Seeking Alpha
- BXMT Q2 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 2/12/26 - Beat
ALNY
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/7/26 - Form 4
- 4/7/26 - Form 3
- ALNY's page on the SEC website